Potent enhancement of transdermal absorption and stability of human tyrosinase plasmid (pAH7/Tyr) by Tat peptide and an entrapment in elastic cationic niosomes

Drug Delivery

Volumn 20, Issue 1, 2013, Pages 10-18

  Manosroi, Jiradej ^a,b   Khositsuntiwong, Narinthorn ^a   Manosroi, Worapaka ^c   Götz, Friedrich ^d   Werner, Rolf G ^e   Manosroi, Aranya ^a,b  

^a CHIANG MAI UNIVERSITY   (Thailand)

^b Science and Technology Research Institute (STRI)   (Thailand)

^c Faculty of Medicine Chiang Mai University   (Thailand)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Elastic cationic niosomes; Human tyrosinase plasmid; Stability; Tat peptide; Transdermal absorption

Indexed keywords

CARBOMER; CARBOPOL 980; ELASTIC CATIONIC NIOSOME; NIOSOME; PLASMID VECTOR; TRANSACTIVATOR PROTEIN; TYROSINASE PLASMID; UNCLASSIFIED DRUG;

ARTICLE; DERMIS; DRUG ABSORPTION; DRUG STABILITY; EPIDERMIS; GEL; PRIORITY JOURNAL; TRANSDERMAL DRUG ADMINISTRATION;

ADMINISTRATION, CUTANEOUS; AMINO ACID SEQUENCE; ANIMALS; CATIONS; DRUG STABILITY; ELASTICITY; GENE PRODUCTS, TAT; HUMANS; LIPOSOMES; MALE; MOLECULAR SEQUENCE DATA; MONOPHENOL MONOOXYGENASE; PEPTIDE FRAGMENTS; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; SKIN ABSORPTION; UP-REGULATION;

EID: 84872247846     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2012.742937     Document Type: Article

References (30)

1. Adami RC, Collard WT, Gupta SA, et al. (1998). Stability of peptidecondensed plasmid DNA formulations. J Pharm Sci 87:678-83.
2. Almofti MR, Harashima H, Shinohara Y, et al. (2003). Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. Arch Biochem Biophys 410:246-53.
3. Avinash HH, Thorat YS, Kastur PV. (2006). Carbopol and its pharmaceutical significance: a review. Pharmaceut Rev 4:1-20
4. Bouwstra JA, Honeywell-Nguyen PL. (2002). Skin structure and mode of action of vesicles. Adv Drug Deliv Rev 54:41-55.
5. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, Ponec M. (2003). Structure of the skin barrier and its modulation by vesicular formulations. Progr Lipid Res 42:1-36.
6. Choi MJ, Maibach HI. (2005). Elastic vesicles as topical/transdermal drug delivery systems. Int J Cosmet Sci 27:211-21.
7. Desai P, Patlolla RR, Singh M. (2010). Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug delivery. Mol Membr Biol 27:247-59.
8. Dutkiewicz R, Albert DM, Levin LA. (2000). Effects of latanoprost on tyrosinase activity and mitotic index of cultured melanoma lines. Exp Eye Res 70:563-9.
9. Eum WS, Jang SH, Kim DW, et al. (2005). Enhanced transduction of Cu, Zn-superoxide dismutase with HIV-1 Tat protein transduction domains at both termini. Mol Cells 19:191-7.
10. Hatanaka T, Shimoyama M, Sugibayashi K, Morimoto Y. (1993). Effect of vehicles on the skin permeability of drugs: polyethylene glycol 400-water and ethanol-water binary solvents. J Control Release 23:247-60.
11. Kang MJ, Eum JY, Jeong MS, et al. (2010). Facilitated skin permeation of oregonin by elastic liposomal formulations and suppression of atopic dermatitis in NC/Nga mice. Biol Pharm Bull 33:100-6.
12. Kikuchi H, Suzuki N, Ebihara K, et al. (1999). Gene delivery using liposome technology. J Control Release 62:269-77.
13. Kim DW, Eum WS, Jang SH, et al. (2003). Ginsenosides enhance the transduction of tat-superoxide dismutase into mammalian cells and skin. Mol Cells 16:402-6.
14. Knutson K, Krill SL, Zhang J. (1990). Solvent-mediated alterations of the stratum corneum. J Control Release 11:93-103.
15. Jo V, Krassimira Y, Annick L. (2004). Influence of the homogenization procedure on the physicochemical properties of PLGA nanoparticles. Chem Pharm Bull (Tokyo) 50:1273-9.
16. Lim JM, Chang MY, Park SG, et al. (2003). Penetration enhancement in mouse skin and lipolysis in adipocytes by TAT-GKH, a new cosmetic ingredient. J Cosmet Sci 54:483-91.
17. Lopes LB, Furnish E, Komalavilas P, et al. (2008). Enhanced skin penetration of P20 phosphopeptide using protein transduction domains. Eur J Pharm Biopharm 68:441-5.
18. Manosroi A, Jantrawut P, Manosroi J. (2008). Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm 360:156-63.
19. Manosroi A, Khanrin P, Lohcharoenkal W, et al. (2010a). Transdermal absorption ehhancement through rat skin of gallidermin loaded in niosomes. Int J Pharm 392:304-10.
20. Manosroi J, Khositsuntiwong N, Go?tz F, et al. (2010b). Enhancement of transdermal absorption, gene expression and stability of tyrosinase plasmid (pMEL34) loaded elastic cationic niosomes: potential application in vitiligo treatment. J Pharm Sci 99:3533-41.
21. Manosroi A, Ruksiriwanich W, Abe M, et al. (2012). Transfolliculer enhancement of gel containing cationic niosomes loaded with unsaturated fatty acids in rice (Oryza sativa) bran semi-purifies fraction. Eur J Pharm Biopharm 81:303-13.
22. Megrab NA, Williams AC, Barry BW. (1995). Oestradiol permeation across human skin, silastic, and snake skin membrenes: the effects of ethanol/water co-solvent systems. Int J Pharm 116:101-12.
23. Park J, Ryu J, Jin LH, et al. (2002). 9-Polylysine protein transduction domain: enhanced penetration efficiency of superoxide dismutase into mammalian cells and skin. Mol Cells 13:202-8.
24. Patel D, Patel N, Parmar M, Kaur N. (2011). Transdermal drug delivery system: review. Int J Biopharm Toxicol Res 1:61-80.
25. Prausnitz MR, Bose VG, Langer R, Weaver JC. (1993). Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. Proc Natl Acad Sci USA 90:10504-8.
26. Prausnitz MR, Mitragotri S, Langer R. (2004). Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov 3:115-24.
27. Radler JO, Koltover I, Salditt T, Safinya CR. (1997). Structure of DNA-cationic liposome complexes: DNA intercalation in multilamellar membranes in distinct interhelical packing regimes. Science 275:810-14.
28. Rothbard JB, Garlington S, Lin Q, et al. (2000). Conjugation of arginine oligomers to cyclosporine A facilitates topical delivery and inhibition of inflammation. Nat Med 6:1253-7.
29. Sternberg B, Sorgi FL, Huang L. (1994). New structures in complex formation between DNA and cationic liposomes visualized by freezefracture electron microscopy. FEBS Lett 356:361-6.
30. Varshosaz J, Pardakhty A, Hajhashemi VI, Najafabadi AR. (2003). Development and physical characterization of sorbitan monoester niosomes for insulin oral delivery. Drug Deliv 10:251-62.